Warby Parker Inc. (WRBY)

USD 14.35

(0.6%)

Total Liabilities Summary of Warby Parker Inc.

  • Warby Parker Inc.'s latest annual total liabilities in 2023 was 278.52 Million USD , down -1.25% from previous year.
  • Warby Parker Inc.'s latest quarterly total liabilities in 2024 Q2 was 288.81 Million USD , up 4.38% from previous quarter.
  • Warby Parker Inc. reported annual total liabilities of 282.06 Million USD in 2022, up 82.39% from previous year.
  • Warby Parker Inc. reported annual total liabilities of 154.64 Million USD in 2021, up 13.43% from previous year.
  • Warby Parker Inc. reported quarterly total liabilities of 288.81 Million USD for 2024 Q2, up 4.38% from previous quarter.
  • Warby Parker Inc. reported quarterly total liabilities of 278.52 Million USD for 2023 FY, down -1.25% from previous quarter.

Annual Total Liabilities Chart of Warby Parker Inc. (2023 - 2019)

Historical Annual Total Liabilities of Warby Parker Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 278.52 Million USD -1.25%
2022 282.06 Million USD 82.39%
2021 154.64 Million USD 13.43%
2020 136.33 Million USD 33.06%
2019 102.46 Million USD 0.0%

Peer Total Liabilities Comparison of Warby Parker Inc.

Name Total Liabilities Total Liabilities Difference
Alcon Inc. 8.98 Billion USD 96.901%
AptarGroup, Inc. 2.13 Billion USD 86.927%
Baxter International Inc. 19.8 Billion USD 98.594%
Becton, Dickinson and Company 26.98 Billion USD 98.968%
Bausch + Lomb Corporation 6.52 Billion USD 95.729%
Haemonetics Corporation 1.23 Billion USD 77.459%
Envista Holdings Corp 2.43 Billion USD 88.544%
ResMed Inc. 2 Billion USD 86.132%
Teleflex Incorporated 3.09 Billion USD 90.991%
West Pharmaceutical Services, Inc. 948.5 Million USD 70.635%